Intracellular Interaction of Interleukin (IL)-32α with Protein Kinase Cϵ (PKCϵ) and STAT3 Protein Augments IL-6 Production in THP-1 Promonocytic Cells*

Background: IL-32α is known to interact with FAK1, and IL-32α overexpression in chronic myeloid leukemia cells increases natural killer cell-mediated killing. Results: IL-32α interacted with PKCϵ and STAT3, mediated STAT3 phosphorylation, and thereby augmented IL-6 production. Conclusion: IL-32α elevated IL-6 production through interaction with PKCϵ and STAT3. Significance: The interaction of IL-32α with PKCϵ and STAT3 reveals a new intracellular mediatory role of IL-32α. IL-32α is known as a proinflammatory cytokine. However, several evidences implying its action in cells have been recently reported. In this study, we present for the first time that IL-32α plays an intracellular mediatory role in IL-6 production using constitutive expression systems for IL-32α in THP-1 cells. We show that phorbol 12-myristate 13-acetate (PMA)-induced increase in IL-6 production by IL-32α-expressing cells was higher than that by empty vector-expressing cells and that this increase occurred in a time- and dose-dependent manner. Treatment with MAPK inhibitors did not diminish this effect of IL-32α, and NF-κB signaling activity was similar in the two cell lines. Because the augmenting effect of IL-32α was dependent on the PKC activator PMA, we tested various PKC inhibitors. The pan-PKC inhibitor Gö6850 and the PKCϵ inhibitor Ro-31-8220 abrogated the augmenting effect of IL-32α on IL-6 production, whereas the classical PKC inhibitor Gö6976 and the PKCδ inhibitor rottlerin did not. In addition, IL-32α was co-immunoprecipitated with PMA-activated PKCϵ, and this interaction was totally inhibited by the PKCϵ inhibitor Ro-31-8220. PMA-induced enhancement of STAT3 phosphorylation was observed only in IL-32α-expressing cells, and this enhancement was inhibited by Ro-31-8220, but not by Gö6976. We demonstrate that IL-32α mediated STAT3 phosphorylation by forming a trimeric complex with PKCϵ and enhanced STAT3 localization onto the IL-6 promoter and thereby increased IL-6 expression. Thus, our data indicate that the intracellular interaction of IL-32α with PKCϵ and STAT3 promotes STAT3 binding to the IL-6 promoter by enforcing STAT3 phosphorylation, which results in increased production of IL-6.

[1]  Kyongmin Kim,et al.  NF-κB and STAT3 cooperatively induce IL6 in starved cancer cells , 2012, Oncogene.

[2]  L. Joosten,et al.  Interleukin 32 (IL-32) Contains a Typical α-Helix Bundle Structure That Resembles Focal Adhesion Targeting Region of Focal Adhesion Kinase-1* , 2011, The Journal of Biological Chemistry.

[3]  Hyeyoung Min,et al.  Overexpression of IL-32α Increases Natural Killer Cell-mediated Killing through Up-regulation of Fas and UL16-binding protein 2 (ULBP2) Expression in Human Chronic Myeloid Leukemia Cells* , 2011, The Journal of Biological Chemistry.

[4]  L. Joosten,et al.  Tumour necrosis factor alpha-driven IL-32 expression in rheumatoid arthritis synovial tissue amplifies an inflammatory cascade , 2010, Annals of the rheumatic diseases.

[5]  Sun Park,et al.  STAT3 transcriptional factor activated by reactive oxygen species induces IL6 in starvation-induced autophagy of cancer cells , 2010, Autophagy.

[6]  C. Dinarello,et al.  Paradoxical effects of constitutive human IL-32γ in transgenic mice during experimental colitis , 2010, Proceedings of the National Academy of Sciences.

[7]  D. Yoon,et al.  A proinflammatory cytokine interleukin‐32β promotes the production of an anti‐inflammatory cytokine interleukin‐10 , 2009, Immunology.

[8]  P. Lin,et al.  Molecular characterization of IL-32 in human endothelial cells. , 2009, Cytokine.

[9]  O. Inatomi,et al.  Interleukin-32 Expression in the Pancreas , 2009, The Journal of Biological Chemistry.

[10]  N. Voelkel,et al.  IL-32–dependent effects of IL-1β on endothelial cell functions , 2009, Proceedings of the National Academy of Sciences.

[11]  Soohyun Kim,et al.  Tumor necrosis factor alpha-induced interleukin-32 is positively regulated via the Syk/protein kinase Cdelta/JNK pathway in rheumatoid synovial fibroblasts. , 2009, Arthritis and rheumatism.

[12]  Michael A Gorin,et al.  Protein kinase Cε: an oncogene and emerging tumor biomarker , 2009, Molecular Cancer.

[13]  G. Mabilleau,et al.  Interleukin-32 Promotes Osteoclast Differentiation but Not Osteoclast Activation , 2009, PloS one.

[14]  C. Dinarello,et al.  IL-32, a novel proinflammatory cytokine in chronic obstructive pulmonary disease. , 2008, American journal of respiratory and critical care medicine.

[15]  Y. Shirai,et al.  Protein kinase Cε: function in neurons , 2008, The FEBS journal.

[16]  D. Yoon,et al.  Interleukin-32 monoclonal antibodies for immunohistochemistry, Western blotting, and ELISA. , 2008, Journal of immunological methods.

[17]  T. McMahon,et al.  Amygdala protein kinase C epsilon regulates corticotropin‐releasing factor and anxiety‐like behavior , 2008, Genes, brain, and behavior.

[18]  L. Joosten,et al.  Interleukin-32 induces the differentiation of monocytes into macrophage-like cells , 2008, Proceedings of the National Academy of Sciences.

[19]  A. Takayanagi,et al.  Phosphatidylinositol 3-kinase/Akt signaling mediates interleukin-32alpha induction in human pancreatic periacinar myofibroblasts. , 2008, American journal of physiology. Gastrointestinal and liver physiology.

[20]  D. Mochly‐Rosen,et al.  Mitochondrial protein kinase Cepsilon (PKCepsilon): emerging role in cardiac protection from ischaemic damage. , 2007, Biochemical Society transactions.

[21]  D. Mochly‐Rosen,et al.  The roles of PKCδ and ϵ isoenzymes in the regulation of myocardial ischaemia/reperfusion injury , 2007 .

[22]  G. Wilding,et al.  Protein kinase Cepsilon interacts with signal transducers and activators of transcription 3 (Stat3), phosphorylates Stat3Ser727, and regulates its constitutive activation in prostate cancer. , 2007, Cancer research.

[23]  A. Takayanagi,et al.  Epithelial overexpression of interleukin‐32α in inflammatory bowel disease , 2007 .

[24]  A. Basu,et al.  Protein kinase Cε makes the life and death decision , 2007 .

[25]  M. Aziz,et al.  Protein kinase Cε interacts with Stat3 and regulates its activation that is essential for the development of skin cancer , 2007, Molecular carcinogenesis.

[26]  D. Smyth,et al.  Oncostatin M-Induced IL-6 Expression in Murine Fibroblasts Requires the Activation of Protein Kinase Cδ1 , 2006, The Journal of Immunology.

[27]  J. Basu,et al.  TLR4-Dependent NF-κB Activation and Mitogen- and Stress-Activated Protein Kinase 1-Triggered Phosphorylation Events Are Central to Helicobacter pylori Peptidyl Prolyl cis-, trans-Isomerase (HP0175)-Mediated Induction of IL-6 Release from Macrophages1 , 2006, The Journal of Immunology.

[28]  L. Joosten,et al.  Mycobacterium tuberculosis Induces Interleukin-32 Production through a Caspase- 1/IL-18/Interferon-γ-Dependent Mechanism , 2006, PLoS medicine.

[29]  Hideyuki Yamamoto,et al.  The linoleic acid derivative DCP-LA selectively activates PKC-ϵ, possibly binding to the phosphatidylserine binding site Published, JLR Papers in Press, March 6, 2006. , 2006, Journal of Lipid Research.

[30]  Do-Young Yoon,et al.  IL-32, a proinflammatory cytokine in rheumatoid arthritis. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[31]  S. Ohno,et al.  Involvement of IL-32 in activation-induced cell death in T cells. , 2006, International immunology.

[32]  M. Goldman,et al.  Protein kinase C epsilon: a new target to control inflammation and immune-mediated disorders. , 2004, The international journal of biochemistry & cell biology.

[33]  J. Raber,et al.  Decreased anxiety-like behavior, reduced stress hormones, and neurosteroid supersensitivity in mice lacking protein kinase Cepsilon. , 2002, The Journal of clinical investigation.

[34]  G. O'Neill,et al.  Tumor Necrosis Factor- α –Induced Secretion of RANTES and Interleukin-6 from Human Airway Smooth Muscle Cells: Modulation by Glucocorticoids and β -Agonists , 2002 .

[35]  Daria Mochly-Rosen,et al.  Adaptor proteins in protein kinase C-mediated signal transduction , 2001, Oncogene.

[36]  Y. Tokumitsu,et al.  Calcitonin induces IL-6 production via both PKA and PKC pathways in the pituitary folliculo-stellate cell line. , 2001, Endocrinology.

[37]  A. Hoffmann,et al.  Regulation of IL-6 and IL-8 Expression in Rheumatoid Arthritis Synovial Fibroblasts: the Dominant Role for NF-κB But Not C/EBPβ or c-Jun1 , 2000, The Journal of Immunology.

[38]  P. Kovanen,et al.  Regulation of Jak2 tyrosine kinase by protein kinase C during macrophage differentiation of IL-3-dependent myeloid progenitor cells. , 2000, Blood.

[39]  T. Hershko,et al.  Expression of PKCeta in NIH-3T3 cells promotes production of the pro-inflammatory cytokine interleukin-6. , 1999, European cytokine network.

[40]  J. Levine,et al.  A Novel Nociceptor Signaling Pathway Revealed in Protein Kinase C ε Mutant Mice , 1999, Neuron.

[41]  Tong Zhang,et al.  Protein Kinase C δ Associates with and Phosphorylates Stat3 in an Interleukin-6-dependent Manner* , 1999, The Journal of Biological Chemistry.

[42]  B. Schwartz,et al.  Protein kinase C in erythroid and megakaryocytic differentiation: possible role in lineage determination. , 1997, Biochimica et biophysica acta.

[43]  P. Leder,et al.  Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia , 1996, Nature Medicine.

[44]  A. Newton,et al.  Protein Kinase C: Structure, Function, and Regulation (*) , 1995, The Journal of Biological Chemistry.

[45]  E. Huberman,et al.  Protein kinase C-beta is required for macrophage differentiation of human HL-60 leukemia cells. , 1994, The Journal of biological chemistry.

[46]  H. Mischak,et al.  Phorbol ester-induced myeloid differentiation is mediated by protein kinase C-alpha and -delta and not by protein kinase C-beta II, -epsilon, -zeta, and -eta. , 1993, The Journal of biological chemistry.

[47]  Haruki Hasegawa,et al.  Native IL-32 is released from intestinal epithelial cells via a non-classical secretory pathway as a membrane-associated protein. , 2011, Cytokine.

[48]  西田 淳史.  Phosphatidylinositol 3-kinase/Akt signaling mediates interleukin-32α induction in human pancreatic periacinar myofibroblasts , 2009 .

[49]  R. Messing,et al.  Intracellular signaling pathways that regulate behavioral responses to ethanol. , 2006, Pharmacology & therapeutics.

[50]  Hideyuki Yamamoto,et al.  The linoleic acid derivative DCP-LA selectively activates PKC-epsilon, possibly binding to the phosphatidylserine binding site. , 2006, Journal of lipid research.

[51]  D. Yoon,et al.  Interleukin-32: a cytokine and inducer of TNFalpha. , 2005, Immunity.

[52]  D. Yoon,et al.  Interleukin-32A Cytokine and Inducer of TNFα , 2005 .

[53]  O. Eickelberg,et al.  Transforming growth factor-beta1 induces interleukin-6 expression via activating protein-1 consisting of JunD homodimers in primary human lung fibroblasts. , 1999, The Journal of biological chemistry.